Latest Intellectual Property News

Aeeris Ltd reported solid growth in Q2 FY25, driven by increased annual recurring revenue and new contracts across key sectors, while unveiling a promising new technology set to expand its market footprint.

Weebit Nano has solidified its position in the semiconductor memory sector by signing a major licensing agreement with onsemi and raising A$50 million in capital. The company is well-funded and advancing multiple commercial and technical milestones.

Adisyn Ltd has completed its transformative acquisition of 2D Generation, securing a $10 million capital raise to accelerate development of graphene-enhanced semiconductor technologies. The company is positioning itself to disrupt key markets including defence, data centres, and cybersecurity.

KneoMedia reports a successful quarter marked by significant capital raises and expanding deployments of its KneoScience platform across New York City schools, positioning the company for sustained revenue growth.

EcoGraf Limited advances its vertically integrated battery anode materials business with a significant UFK loan mandate and progress across upstream, midstream, and downstream operations.

Codeifai Limited has terminated its exclusive licence with MIT and launched a strategic review of its material science division, signaling a decisive pivot towards digital and AI-driven brand solutions.

Firebird Metals Limited has secured preliminary design approval for its battery-grade manganese sulphate plant in China and forged a strategic partnership to develop LMFP cathode materials, marking significant progress in its EV battery ambitions.

Identitii reports solid quarterly progress highlighted by a strategic new director appointment, US market expansion, and a successful $1.8 million capital raise, underpinning its path toward profitability.

ClearVue Technologies has secured key manufacturing and distribution agreements across the Middle East, China, and the UK, while acquiring ROOTS Sustainable Agricultural Technologies to bolster its net zero ag-tech solutions.

Appen's Q4 FY24 results reveal a robust 37% revenue increase excluding Google, alongside improved EBITDA profitability, driven by generative AI projects and strategic cost management.

Cynata Therapeutics reports encouraging Phase 1 results for its diabetic foot ulcer treatment CYP-006TK, alongside a strengthened balance sheet and ongoing clinical progress.

Bio-Gene Technology Limited has advanced its bio-insecticide pipeline with two U.S. Department of Defense grants totaling A$3 million, alongside key regulatory and production milestones for Flavocide® and Qcide®.